Relationship of tumor necrosis factor genetic polymorphisms with the clinical course and outcome of non-Hodgkin's lymphoma

Chinese Journal of Clinical Oncology

Volumn 37, Issue 1, 2010, Pages 23-28

  Zhao, Hongyun ^a,b   Zhong, Xueyun ^c   Chen, Yunxian ^b  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

Gene polymorphism; Non Hodgkin's lymphoma; Tumor necrosis factor

Indexed keywords

LYMPHOTOXIN; TUMOR NECROSIS FACTOR;

ARTICLE; CANCER PATIENT; CANCER SURVIVAL; CANCER THERAPY; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POLYMERASE CHAIN REACTION; PROGRESSION FREE SURVIVAL;

EID: 79953649929     PISSN: 10008179     EISSN: None     Source Type: Journal    
DOI: 10.3969/j.issn.1000-8179.2010.01.007     Document Type: Article

References (17)

1. Salles G, Bienvenu J, Bastion Y, et al. Elevated circulating levels of TNF alpa and its p55 soluble receptor are associated with an adverse prognosis in lymphoma patients[J]. Br J Haematol, 1996,93(2):352-359. (Pubitemid 26148739)
2. Warzocha K, Salles G, Bienvenu J, et al. The tumor necrosis factor ligand-receptor system can predict treatment outcome in lymphoma patients[J]. J Clin Oncol, 1997,15(2):499-508.
3. Gibbons DL, Rowe M, Cope AP, et al. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines[J]. Eur J Immunol, 1994,24(8):1879-1885. (Pubitemid 24237562)
4. Maeda M, Watanabe N, Okamoto T, et al. Endogenous tumor necrosis factor functions as a resistant factor against adriamycin[J]. Int J Cancer, 1994,58(3):376-379. (Pubitemid 24254647)
5. Juszczynski P, Kalinka E, Bienvenu J, et al. Human leukocyte antigens class II and tumor necrosis factor genetic polymorphisms are independent predictors of non-Hodgkin lymphoma outcome.[J]. Blood, 2002,100(8):3037-3040.
6. Loparev VN, Cartas MA, Monken CE, et al. An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents[J]. J Virol Methods, 1991,34(1):105-112.
7. Wilson AG, de Vries N, Pociot F, et al. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLAA1,B8 and DR3 alleles[J]. J Exp Med, 1993,177(2):557-560. (Pubitemid 23117109)
8. Warzocha K, Ribeiro P, Bienvenu J, et al. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome[J]. Blood, 1998,91(10):3574-3581. (Pubitemid 28225722)
9. Pasparakis M, Alexopoulou L, Episkopou V, et al. Immune and inflammatory responses in TNF-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic networks and germinal centers, and in the maturation of the humoral immune response[J]. J Exp Med, 1996,184(4):1397-1411. (Pubitemid 26354696)
10. Messer G, Spengler U, Jung MC, et al. Polymorphic structure of the tumor necrosis factor(TNF) locus: an Nco I polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production[J]. J Exp Med, 1991,173(1):209-219.
11. Jevtovic-Stoimenov T, Kocic G, Pavlovic D, et al. Polymorphisms of tumor-necrosis factor-alpha-308 and lymphotoxin-alpha + 250: possible modulation of susceptibility to apoptosis in chronic lymphocytic leukemia and non-Hodgkin lymphoma mononuclear cells[J]. Leuk Lymphoma, 2008,49(11):2163-2169.
12. Sallusto F, Nicolo C, De Maria R, et al. Ceramide inhibits antigen uptake and presentation by dendritic cells[J]. J Exp Med, 1996,184(6):2411-2416. (Pubitemid 27023741)
13. Tilg H, Jalan R, Kaser A, et al. And-tumor necrosis factor-alpha monoclonal antibody therapy in severe alcoholic hepatitis[J]. J Hepatol, 2003,38(4):419-425. (Pubitemid 36399243)
14. Totsuka T, Kanai T, Uraushihara K, et al. Therapeutic effect of and-OX40L and anti-TNF-alpha MAbs in a murine model of chronic colitis[J]. Am J Physiol Gastrointest Liver Physiol, 2003,284(4):G595-G603. (Pubitemid 36343209)
15. Spink CF, Keen LJ, Mensah FK, et al. Association between non-Hodgkin lymphoma and haplotypes in the TNF region[J]. Br J Haematol, 2006,133(3):293-300.